Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE …
U Mrowietz, J Barker, C Conrad… - Journal of the …, 2023 - Wiley Online Library
Abstract Introduction/Background Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
[PDF][PDF] Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the …
U Mrowietz, J Barker, C Conrad, D Jullien, P Gisondi… - 2022 - macau.uni-kiel.de
Abstract Introduction/Background: Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE …
M Ulrich, B Jonathan, C Curdin, J Denis… - JOURNAL OF THE …, 2023 - iris.univr.it
Abstract Introduction/Background Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE …
U Mrowietz, J Barker, C Conrad… - Journal of the …, 2023 - search.ebscohost.com
Abstract Introduction/Background: Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
[PDF][PDF] Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the …
U Mrowietz, J Barker, C Conrad, D Jullien, P Gisondi… - 2022 - serval.unil.ch
Abstract Introduction/Background: Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
Efficacy and Safety of Apremilast in Patients With Limited Skin Involvement, Plaque Psoriasis in Special Areas, and Impaired Quality of Life: Results From the …
U Mrowietz, J Barker, C Conrad, D Jullien… - Journal of the …, 2022 - europepmc.org
Objective The objective of EMBRACE was to evaluate the impact on QoL, efficacy, and
safety of apremilast 30 mg BID in patients with limited skin involvement with plaque psoriasis …
safety of apremilast 30 mg BID in patients with limited skin involvement with plaque psoriasis …
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE …
U Mrowietz, J Barker, C Conrad… - Journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction/background Manifestations of psoriasis in special areas are difficult to treat and
are associated with a high disease burden and significant quality of life (QoL) impairment …
are associated with a high disease burden and significant quality of life (QoL) impairment …
[PDF][PDF] Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the …
U Mrowietz, J Barker, C Conrad, D Jullien, P Gisondi… - 2022 - serval.unil.ch
Abstract Introduction/Background: Manifestations of psoriasis in special areas are difficult to
treat and are associated with a high disease burden and significant quality of life (QoL) …
treat and are associated with a high disease burden and significant quality of life (QoL) …
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE …
U Mrowietz, J Barker, C Conrad, D Jullien… - Journal of the …, 2023 - macau.uni-kiel.de
Objective The objective of EMBRACE was to evaluate the impact on QoL, efficacy and safety
of apremilast 30 mg BID in patients with limited skin involvement with plaque psoriasis …
of apremilast 30 mg BID in patients with limited skin involvement with plaque psoriasis …